Ultragenyx Pharmaceutical...
(RARE)
undefined
undefined%
At close: undefined
43.60
2.30%
Pre-market Jan 07, 2025, 06:41 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -606.64M | -707.42M | -454.02M | -186.57M | -402.73M | -197.61M | -302.14M | -245.87M | -145.62M | -59.80M | -35.07M | -16.33M | -6.85M |
| Depreciation & Amortization | 26.01M | 18.22M | 13.24M | 12.26M | 8.54M | 19.54M | 5.83M | 3.42M | 1.38M | 684.00K | 444.00K | 313.00K | 34.00K |
| Stock-Based Compensation | 135.21M | 130.38M | 104.95M | 85.73M | 82.00M | 80.11M | 68.01M | 48.31M | 24.88M | 5.39M | 657.00K | 891.00K | 254.00K |
| Other Working Capital | 12.23M | -5.44M | -57.49M | 66.57M | -12.04M | -15.30M | -23.69M | 23.80M | 9.72M | -1.01M | -1.78M | 1.47M | 201.00K |
| Other Non-Cash Items | -12.67M | 119.76M | 11.71M | 21.46M | 1.69M | -156.00K | 10.93M | 700.00K | 5.64M | 6.92M | 4.31M | 302.00K | 270.00K |
| Deferred Income Tax | -1.62M | -1.64M | 48.67M | -169.78M | -18.94M | -167.65M | -16.25M | 6.16M | n/a | n/a | n/a | n/a | 13.00K |
| Change in Working Capital | -15.10M | 60.23M | -63.24M | 104.66M | -15.94M | -24.79M | -20.23M | 26.30M | 7.74M | 2.17M | -1.54M | 2.32M | 453.00K |
| Operating Cash Flow | -474.81M | -380.46M | -338.69M | -132.22M | -345.38M | -290.57M | -253.84M | -160.97M | -105.98M | -44.63M | -31.20M | -12.50M | -5.83M |
| Capital Expenditures | -46.77M | -146.12M | -73.09M | -43.91M | -24.83M | -4.08M | -2.79M | -10.19M | -4.96M | -2.15M | -407.00K | -1.09M | -548.00K |
| Acquisitions | n/a | -75.03M | n/a | n/a | -11.79M | n/a | -142.80M | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -526.38M | -614.74M | -1.01B | -850.30M | -707.16M | -509.80M | -230.49M | -442.49M | -624.23M | -208.97M | -63.95M | n/a | n/a |
| Sales Maturities Of Investments | 746.20M | 545.08M | 890.85M | 720.64M | 718.96M | 310.22M | 431.57M | 543.79M | 338.37M | 87.97M | 16.60M | n/a | n/a |
| Other Investing Acitivies | -7.55M | -844.00K | -942.00K | -5.55M | 11.79M | 170.32M | 934.00K | -1.20M | -1.54M | -293.00K | 25.00K | -100.00K | -376.00K |
| Investing Cash Flow | 168.00M | -291.65M | -195.37M | -179.12M | -13.04M | -33.33M | 56.42M | 89.92M | -292.35M | -123.44M | -47.73M | -1.19M | -924.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -4.94M | n/a | n/a | n/a | n/a | 100.00K | 2.45M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.35M | n/a | n/a | n/a |
| Other Financial Acitivies | 8.39M | 501.21M | 39.61M | 89.06M | 324.06M | 27.83M | 9.25M | 59.19M | 6.44M | 736.00K | n/a | 89.01M | 14.88M |
| Financial Cash Flow | 388.14M | 501.21M | 118.55M | 600.27M | 679.31M | 336.85M | 136.27M | 138.68M | 467.57M | 184.97M | 171.00K | 89.24M | 17.33M |
| Net Cash Flow | 81.80M | -171.98M | -416.71M | 290.05M | 320.72M | 12.48M | -60.63M | 67.55M | 69.25M | 16.90M | -78.76M | 75.55M | 10.58M |
| Free Cash Flow | -521.57M | -526.59M | -411.79M | -176.13M | -370.21M | -294.64M | -256.64M | -171.16M | -110.93M | -46.78M | -31.61M | -13.60M | -6.37M |